Braveheart Investment Group plc

Equities

BRH

GB00B13XV322

Investment Management & Fund Operators

Market Closed - London S.E. Other stock markets 16:35:04 31/05/2024 BST			5-day change	1st Jan Change
5.25 ^GBX	-.--%		+5.00%	-40.00%

05-17	Braveheart writes down value of two investments	AN
03-06	Braveheart buys 4 million Autins shares for GBP320,000	AN

Braveheart's Phasefocus investment aims push into the US

May 31, 2023 at 07:42 pm

Braveheart Investment Group PLC - Barnsley, England-based investor in small- and medium-sized businesses - Provides update on Phasefocus Holdings Ltd, in which Braveheart has a 44% holding. Notes Phasefocus recently appointed Nexus Scientific, a specialist in cell analysis instrument sales, to represent Livecyte products in North America. Livecyte is an imaging and analysis system which uses a novel method for high fidelity quantitative imaging and microscopy. Explains Nexus will be running a series of customer workshops, conference attendances and seminars, to raise the profile and sales of Livecyte in the US. Further, notes two new Livecyte applications have been developed and are scheduled for launch before the end of 2023.

Current stock price: 12.90 pence, up 12% in London on Wednesday

12-month change: up 5.3%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Latest news about Braveheart Investment Group plc

Braveheart writes down value of two investments	05-17	AN
Braveheart buys 4 million Autins shares for GBP320,000	03-06	AN
Braveheart Investment Group Raises Autins Group Stake	03-06	MT
Braveheart Investment Group plc (AIM : BRH) acquired 7.33% skate in Autins Group plc (AIM : AUTG) for approximately £0.32 million.	03-05	CI
Beowulf raises funds for Kallak iron ore project	03-04	AN
Beowulf ups Vardar stake; Impellam buyout nears	03-04	AN
Braveheart Investment Group Closes Sale of Phasefocus Holdings Unit to Bruker UK	03-04	MT
Bruker Uk Limited completed the acquisition of Phasefocus Holdings Limited from Braveheart Investment Group plc and other shareholders.	03-03	CI
Braveheart Investment to sell Phasefocus for GBP5 million	12-22	AN
Braveheart Investment to Receive GBP2 Million Via Subsidiary Sale	12-22	MT
Braveheart Investment Announces Sale Of Phasefocus	12-22	RE
Bruker Uk Limited entered into a conditional sale and purchase agreement to acquire Phasefocus Holdings Limited from Braveheart Investment Group plc and other shareholders for £5 million.	12-21	CI
EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens	12-15	AN
EARNINGS AND TRADING: abrdn Diversified Income to begin wind-down	12-14	AN
Earnings Flash (BRH.L) BRAVEHEART INVESTMENT GROUP Reports Fiscal H1 Revenue GBP46,494	12-14	MT
Earnings Flash (BRH.L) BRAVEHEART INVESTMENT GROUP Posts Fiscal H1 Loss GBX-1.15	12-14	MT
Braveheart Investment Group plc Reports Earnings Results for the Half Year Ended September 30, 2023	12-14	CI
Braveheart Investment firm gets first CX300 detector sales contract	11-29	AN
Braveheart Investment investee Paraytec updates on CX300	17/10/23	AN
Braveheart Investment investee Kirkstall develops new model	08/09/23	AN
Braveheart invests GBP150,000 in Phasefocus for cancer-focused assay	21/08/23	AN
UK's Braveheart Investment Takes Additional Stake in Phasefocus	21/08/23	MT
Phasefocus Holdings Limited announced that it has received £0.15 million in funding from Braveheart Investment Group plc	20/08/23	CI
Limitless Earth loss widens; Black Sea NAV rises	28/07/23	AN
Braveheart Investment opts for "masterful inactivity" as profit rises	03/07/23	AN

Chart Braveheart Investment Group plc

Duration

Period

More charts

Company Profile

Braveheart Investment Group plc is a United Kingdom-based private equity and venture capital company. The Company divides its investments into two categories, namely strategic investments and portfolio investments. Its strategic investments include companies, including Paraytec Limited (Paraytec), Kirkstall Limited, Autins Group plc, Aukett Swanke Group plc and Image Scan Group plc. Paraytec develops specialist detectors for the analytical and life sciences instrumentation markets. Kirkstall Limited operates in the organ-on-a-chip market where it has developed Quasi Vivo, a system of chambers for cell and tissue culture in laboratories. Autins Group plc specializes in solving acoustic and thermal problems in the automotive industry and other specialist applications. Aukett Swanke Group plc provides architectural and interior design services in the primary international market sectors of offices, residential, education, industrial, hospitality and mixed use or hybrid developments.

Sector

Investment Management & Fund Operators

Calendar

13/06/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
BRAVEHEART INVESTMENT GROUP PLC	-40.00%	4.26M
BLACKROCK, INC.	-4.90%	115B
UBS GROUP AG	+9.16%	101B
BROOKFIELD CORPORATION	+11.67%	67.41B
APOLLO GLOBAL MANAGEMENT, INC.	+24.65%	66.1B
BANK OF NEW YORK MELLON CORPORATION (THE)	+14.52%	44.58B
AMERIPRISE FINANCIAL, INC.	+14.85%	43.37B
3I GROUP PLC	+18.26%	35.13B
T. ROWE PRICE GROUP INC.	+9.42%	26.31B
STATE STREET CORPORATION	-2.41%	22.77B

Other Investment Management & Fund Operators